000 01229 a2200337 4500
005 20250516014138.0
264 0 _c20110516
008 201105s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/138161210794455067
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTrpkovic, Andreja
245 0 0 _aChronic hepatitis C, insulin resistance and vascular disease.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2010
300 _a3823-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aHepatitis C, Chronic
_xcomplications
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aInsulin Resistance
650 0 4 _aObesity
_xcomplications
650 0 4 _aVascular Diseases
_xcomplications
700 1 _aStokic, Edith
700 1 _aRadak, Djordje
700 1 _aGluvic, Zoran
700 1 _aHaidara, Mohamed
700 1 _aMikhailidis, Dimitri P
700 1 _aIsenovic, Esma R
773 0 _tCurrent pharmaceutical design
_gvol. 16
_gno. 34
_gp. 3823-9
856 4 0 _uhttps://doi.org/10.2174/138161210794455067
_zAvailable from publisher's website
999 _c20420329
_d20420329